Prothrombin time in liver failure: Time, ratio, activity percentage, or international normalized ratio?

Hepatology

Volumn 24, Issue 6, 1996, Pages 1392-1394

  Robert, Annie ^a,b   Chazouillères, Olivier ^b  

^a Lab Ctrl d'Hematologie d'Immunol   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPLASTIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; LIVER FAILURE; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; SURVIVAL RATE;

EID: 0029912013     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008938167     Document Type: Article

References (18)

1. Caraceni P, Van Thiel DH. Acute liver failure. Lancet 1995;345:163-169.
2. Munoz SJ. Prothrombin time in fulminant hepatic failure. Gastroenterology 1991;100:1480.
3. O'Grady JG, Gimson AE, O'Brien C, Pucknell A, Hughes R, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-1192.
4. O'Grady JG, Alexander GJ, Hayllar K, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445.
5. Peleman RR, Gavaler JS, Van Thiel DH, Esquivel C, Gordon R, Iwatsuki S, Starzl T. Orthotopic liver transplantation for acute and subacute hepatic failure in adults. HEPATOLOGY 1987;7:484-489.
6. Emond JC, Aran PP, Whitington PF, Broelsch CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989;96:1583-1588.
7. Schafer DF, Shaw BW. Fulminant hepatic failure and orthotopic liver transplantation. Semin Liver Dis 1989;9:189-194.
8. International Committee for the Standardization in Haematology and International Committee on Thrombosis and Haemostasis. ICSH/ISTH recommendations for reporting prothrombin time in oral anticoagulant control. Thromb Haemostas 1985;53:155-156.
9. O'Grady JG, Hambley H, Williams R. Prothrombin time in fulminant hepatic failure. Reply. Gastroenterology 1991;100:1480-1481.
10. Donaldson BW, Gopinath R, Wanless IR, Phillips MJ, Cameron R, Roberts EA, Greig PD, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. HEPATOLOGY 1993; 18:1370-1376.
11. Fang JWS, Bird GLA, Nakamura T, Davis GL, Lau JYN. Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis. Lancet 1994;343:820-823.
12. Murtaugh PA, Dickson ER, Van Dam GM, Malinchoc M, Grambsch PM, Langworthy AL, Gips CH. Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. HEPATOLOGY 1994;20:126-134.
13. Hirsch J, Poller L. The international normalized ratio. Arch Intern Med 1994;154:282-288.
14. Kovacs MJ, Wong A, MacKinnon K, Weir K, Keeney M, Boyle E, Cruickshank M. Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemostas 1994;71:727-730.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-311.
16. Dickson ER, Grambsch PM, Fleming TR, Fischer LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. HEPATOLOGY 1989;10:1-7.
17. Carithers RL, Herlong HF, Diehl AM, Shaw EW, Combes B, Fallon HJ, Maddrey WC. Methylprednisolone therapy in patients with severe alcoholic hepatitis. Ann Intern Med 1989;110:685-690.
18. The Le D, Weibert RT, Sevilla BK, Donnely KJ, Rapaport SI. The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods. Ann Intern Med 1994;120:552-558.